Echinacea
Echinacea species preparations marketed for common-cold prevention or treatment. A Cochrane review found products and trials too heterogeneous for broad conclusions, with no convincing treatment benefit established.
Pharmacokinetic model
A route-level PK model for echinacea is being prepared from published data. Dosing references, studies, and documented interactions are below; the app catalog is updated as models are validated.
Key facts
- Category
- Herb
- Suggested cadence
- once daily
Research behind this entry
-
Echinacea for preventing and treating the common cold
Cochrane review found substantial differences among Echinacea species, plant parts, preparations, and trials. It did not show convincing treatment benefit, while possible preventive signals were small and inconsistent.
-
Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled Trial
Long-term prevention trial tested one proprietary Echinacea purpurea extract. Product-specific findings and multiple outcomes should not be generalized to other species, plant parts, or formulations.
2 published studies referenced in the app, each with a plain-language summary.